The American Journal of Medicine
Volume 122, Issue 3 , Pages 207-214.e4 , March 2009

Risk Factors for Type 2 Diabetes Among Women with Gestational Diabetes: A Systematic Review

  • Kesha Baptiste-Roberts, PhD, MPH

      Affiliations

    • Department of Epidemiology, Johns Hopkins Medical Institutions, Baltimore, Md
    • ,
  • Bethany B. Barone, ScM

      Affiliations

    • Department of Epidemiology, Johns Hopkins Medical Institutions, Baltimore, Md
    • ,
  • Tiffany L. Gary, PhD, MHS

      Affiliations

    • Department of Epidemiology, Johns Hopkins Medical Institutions, Baltimore, Md
    • Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Md
    • ,
  • Sherita H. Golden, MD, MHS

      Affiliations

    • Department of Epidemiology, Johns Hopkins Medical Institutions, Baltimore, Md
    • Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Md
    • ,
  • Lisa M. Wilson, ScM

      Affiliations

    • Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Md
    • ,
  • Eric B. Bass, MD, MPH

      Affiliations

    • Department of Epidemiology, Johns Hopkins Medical Institutions, Baltimore, Md
    • Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Md
    • ,
  • Wanda K. Nicholson, MD, MPH

      Affiliations

    • Department of Obstetrics & Gynecology, Johns Hopkins Medical Institutions, Baltimore, Md
    • Department of Population and Family and Reproductive Health, Johns Hopkins Medical Institutions, Baltimore, Md
    • Corresponding Author InformationRequests for reprints should be addressed to Wanda K. Nicholson, MD, MPH, Department of Obstetrics and Gynecology, Phipps 247, 600 N. Wolfe Street, Baltimore, MD 21205

References 

  1. Ferrara A, Hedderson MM, Quesenberry CP, Selby JV. Prevalence of gestational diabetes mellitus detected by the national diabetes data group or the carpenter and coustan plasma glucose thresholds. Diabetes Care. 2002;25:1625–1630
  2. Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am. 2007;34:173–199vii
  3. Rosenberg TJ, Garbers S, Lipkind H, Chiasson MA. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am J Public Health. 2005;95:1545–1551
  4. Dabelea D, Snell-Bergeon JK, Hartsfield CL, et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care. 2005;28:579–584
  5. Kjos SL, Buchanan TA, Greenspoon JS, et al. Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months post partum. Am J Obstet Gynecol. 1990;163:93–98
  6. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862–1868
  7. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431
  8. Gary TL, Brancati FL. Strategies to curb the epidemic of diabetes and obesity in primary care settings. J Gen Intern Med. 2004;19:1242–1243
  9. Nicholson WK, Wilson LM, Witkop CT, et al. Therapeutic Management, Delivery, and Postpartum Risk Assessment and Screening in Gestational Diabetes (AHRQ Publication No. 08-E004). Rockville, MD: Agency for Healthcare Research and Quality; 2008;
  10. Berlin JA. Does blinding of readers affect the results of meta-analyses? (University of Pennsylvania Meta-analysis Blinding Study Group). Lancet. 1997;350:185–186
  11. Altman D, Egger M, Pocock S, et al. Strengthening the reporting of observational epidemiological studies. STROBE Statement: Checklist of Essential Items. 2005;Version 3
  12. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490
  13. Cheung NW, Helmink D. Gestational diabetes: the significance of persistent fasting hyperglycemia for the subsequent development of diabetes mellitus. J Diabetes Complications. 2006;20:21–25
  14. Cho NH, Lim S, Jang HC, et al. Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study. Diabetes Care. 2005;28:2750–2755
  15. Cho NH, Jang HC, Park HK, Cho YW. Waist circumference is the key risk factor for diabetes in Korean women with history of gestational diabetes. Diabetes Res Clin Pract. 2006;71:177–183
  16. Dacus JV, Meyer NL, Muram D, et al. Gestational diabetes: postpartum glucose tolerance testing. Am J Obstet Gynecol. 1994;171:927–931
  17. Jang HC, Yim CH, Han KO, et al. Gestational diabetes mellitus in Korea: prevalence and prediction of glucose intolerance at early postpartum. Diabetes Res Clin Pract. 2003;61:117–124
  18. Kjos SL, Peters RK, Xiang A, et al. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA. 1998;280:533–538
  19. Lobner K, Knopff A, Baumgarten A, et al. Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes. 2006;55:792–797
  20. Metzger BE, Cho NH, Roston SM, Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care. 1993;16:1598–1605
  21. Pallardo F, Herranz L, Garcia-Ingelmo T, et al. Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care. 1999;22:1053–1058
  22. Peters RK, Kjos SL, Xiang A, Buchanan TA. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet. 1996;347:227–230
  23. Xiang AH, Kawakubo M, Kjos SL, Buchanan TA. Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care. 2006;29:613–617
  24. Kjos SL, Peters RK, Xiang A, et al. Predicting future diabetes in Latino women with gestational diabetes (Utility of early postpartum glucose tolerance testing). Diabetes. 1995;44:586–591
  25. Schaefer-Graf UM, Buchanan TA, Xiang AH, et al. Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol. 2002;186:751–756
  26. Steinhart JR, Sugarman JR, Connell FA. Gestational diabetes is a herald of NIDDM in Navajo women (High rate of abnormal glucose tolerance after GDM). Diabetes Care. 1997;20:943–947
  27. Ratner R. Women with a History of Gestational Diabetes in the Diabetes Prevention Program. Chicago IL: Fourth International Workshop-Conference on Gestational Diabetes Mellitus; 2005;
  28. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes. 2002;51:2796–2803
  29. Xiang AH, Peters RK, Kjos SL, et al. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes. 2006;55:517–522
  30. Kim C, Tabaei BP, Burke R, et al. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health. 2006;96:1643–1648
  31. Smirnakis KV, Chasan-Taber L, Wolf M, et al. Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol. 2005;106:1297–1303
  32. O'Campo P, Faden RR, Brown H, Gielen AC. The impact of pregnancy on women's prenatal and postpartum smoking behavior. Am J Prev Med. 1992;8:8–13

 Funding: This research was supported by the Agency for Healthcare Research and Quality.

 Conflict of Interest: Each author represents and warrants that they have no financial affiliation or involvement with any commercial organization with potential financial interest in the subject or materials discussed in this manuscript except Sherita H. Golden, MD, MHS, who provides consulting services for Merck, Inc. and serves as a member of the US Clinical Diabetes Advisory Board.

 Authorship: Each author participated in the conception and design of this work or the analysis and interpretation of the data, as well as the writing of the manuscript.

 Prior Presentation: American Diabetes Association Scientific Sessions, June 2008.

 Disclaimer: The authors of this article are responsible for its contents, including any clinical or treatment recommendations. No statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality or of the U.S. Department of Health and Human Services.

PII: S0002-9343(08)00981-9

doi: 10.1016/j.amjmed.2008.09.034

The American Journal of Medicine
Volume 122, Issue 3 , Pages 207-214.e4 , March 2009

Article Tools

* Image Usage & Resolution